申请人:VDM Biochemicals, Inc.
公开号:US20220105081A1
公开(公告)日:2022-04-07
The present invention is aimed at providing an opioid antagonist compound and its medical uses. The medical uses the compound of formula (I) (shown below) include complete or partial reversal of narcotic depression with minimal to no withdrawal symptoms, treatment of opioid addiction, depression, opioid withdrawal side effect treatment, schizophrenia, hypertension, scleroderma, dyskinesia, bipolar disorder, ADHD, addictive behaviors, Parkinson's disease, eating disorders, anorexia nervosa, migraine, and memory disorders.